Israeli Scientists Enhance T Cells to Improve Cancer Targeting
Summarized from Ynetnews by baba
CenterNeutral tone
OriginalIsraeli scientists redesign T cells, shrinking tumors in promising cancer studyThe story in 6 lines · by baba
- Israeli researchers redesigned T cells to better target cancer and viruses.
- The engineered T cells, named SET, showed enhanced cancer-killing abilities.
- Computer-assisted protein design was used to modify the T-cell receptor.
- Preclinical trials in mice demonstrated significant tumor shrinkage.
- The approach showed promise against various cancer and viral targets.
- Further research is needed before human clinical trials can begin.
Ynetnews publishes in English. The key points are summarized above. Read Ynetnews’s full report at the source below.
Read the original at YnetnewsMentioned
Full coverage · 2 outlets
First: Ynet · Sep 30The same event, reported separately by each outlet. Open a few to compare what different newsrooms emphasize — and what they leave out.